Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-01-02 @ 9:01 AM
Study NCT ID:
NCT05088057
Status:
UNKNOWN
Last Update Posted:
2021-10-21
First Post:
2021-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer
Sponsor:
Organization: